Clinical management of the acute sunburn reaction

Cutis

Volumn 66, Issue 1, 2000, Pages 53-58

  Driscoll, Marcia S ^a   Wagner Jr , Richard F ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE DISEASE; DRUG COMBINATION; HUMAN; ORAL DRUG ADMINISTRATION; REVIEW; SUNBURN; TOPICAL DRUG ADMINISTRATION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG THERAPY, COMBINATION; HUMANS; SUNBURN;

EID: 0034230806     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Schlesinger IH, Wagner RF Jr, Tyring SK: Potential and limitations of topical sunscreens. Skin Cancer 8: 19-32, 1993.
2. Eberlein-Konig B, Placzek M, Przybilla B: Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and D-a-tocopherol (vitamin E). J Am Acad Dermatol 38: 45-48, 1998.
3. Rhodes LE, Durham BH, Fraser WD, et al: Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increased the threshold to provocation of polymorphic light eruption. J Invest Dermatol 105: 532-535, 1995.
4. Holman CDJ, Armstrong BK, Heenan PJ: Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 76: 403-414, 1986.
5. Gerrish KE, Gensler HL: Prevention of photocarcinogenesis by dietary vitamin E. Nutr Cancer 19: 125-133, 1993.
6. Hill DL, Grubbs CJ: Retinoids and cancer prevention. Ann Rev Nutr 12: 161-181, 1992.
7. Gensler HL: Prevention by alpha-difluoromethylornithine (DMFO) of skin carcinogenesis and immunosuppression induced by ultraviolet radiation. J Cancer Res Clin Oncol 117: 345-350, 1991.
8. Coopman SA, Garmyn M, Gonzales-Serva, et al: Photodamage and photoaging. In, Cutaneous Medicine and Surgery: An Integrated Program in Dermatology ( Ardnt KA, LeBoit PE, Robinson JK, et al, eds), p 736. Philadelphia, WB Saunders, 1996.
9. Hruza LL, Pentland A: Mechanisms of UV-induced inflammation. J Invest Dermatol 100: 35S-41S, 1993.
10. Walsh LJ: Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-alpha. Immunol Cell Biol 73: 226-233, 1993.
11. Gilchrest BA, Soter NA, Stoff JS, et al: The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol 5: 411-422, 1981.
12. Farr PM, Shuster S: Sunburn and neuropeptide depletion. Br J Dermatol 133: 1012, 1995.
13. Greenberg RA, Eaglstein WH, Turnier H, et al: Orally given indomethacin and blood flow response to UVL. Arch Dermatol 111: 328-330, 1975.
14. Cahn MM, Levy EJ: Treatment of acute sunburn reaction with triamcinolone. Arch Dermatol 79: 716, 1959.
15. Younger D, DiPillo F, McGinn T: Corticosteroid therapy in the treatment of erythema solare (sunburn). NY State Med J 58: 2963-2964, 1958.
16. Snyder DS, Eaglstein WH: Intradermal anti-prostaglandin agents and sunburn. J Invest Dermatol 62: 47-50, 1974.
17. Kaidbey KH, Kurban AK: The influence of corticosteroids and topical indomethacin on sunburn erythema. J Invest Dermatol 66: 153-156, 1976.
18. Molloy HF: Sunburn and other superficial burns. The ABCDs of management in the first four hours: a personal view. Med J Aust 154: 263, 1991.
19. Meyer AA, Salber PR: Burns &. smoke inhalation. In, Current Emergency Diagnosis and Treatment (Ho MT, Saunders CE, eds), pp 417-418. Norwalk, Appleton & Lange, 1990.
20. Lane-Brown M: New concepts in prevention and treatment of sunburn. Drugs 13: 366-372, 1977.
21. Greenwald JS, Parrish JA, Jaenicke KF, et al: Failure of systemically administered corticosteroids to suppress UVB-induced delayed erythema. J Am Acad Dermatol 5: 197-202, 1981.
22. Russo PM, Schneiderman LJ: Effect of topical corticosteroids on symptoms of clinical sunburn. J Fam Pract 7: 1129-1132, 1978.
23. Snyder DS, Eaglstein WH: Topical indomethacin and sunburn. Br J Dermatol 90: 91-93, 1974.
24. Sukanto H, Nater JP, Bleumink E: Suppression of ultraviolet erythema by topical corticosteroids. Dermatologica 161: 84-88, 1980.
25. Gruber CM, Ridolfo AS, Nickander R, et al: Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation. Clin Pharmacol Ther 13: 109-113, 1972.
26. Miller WS, Ruderman FR, Smith JG Jr: Aspirin and ultraviolet light-induced erythema in man. Arch Dermatol 95: 357-358, 1967.
27. Morrison WL, Paul BS, Parrish JA: The effects of indomethacin on long-wave ultraviolet-induced delayed erythema. J Invest Dermatol 68: 130-133, 1977.
28. Black AK, Greaves MW, Hensby CN, et al: The effects of indomethacin on arachidonic acid and prostaglandins E2 and F2 alpha levels in human skin 24 hours after UVB and UVC irradiation. Br J Clin Pharmacol 6: 261-266, 1978.
29. Edwards EK, Horwitz SN, Frost P: Reduction of erythema response to ultraviolet light by nonsteroidal antiinflammatory agents. Arch Dermatol Res 272: 263-267, 1982.
30. Stem RS, Dodson TB: Ibuprofen in the treatment of UV-B-induced inflammation. Arch Dermatol 121: 508-512, 1985.
31. Schwarz T, Gshnait F, Greiter F: Photoprotective effect of topical indomethacin - an experimental study. Dermatologica 171: 450-458, 1985.
32. Snyder DS: Cutaneous effects of topical indomethacin, an inhibitor of prostaglandin synthesis, on UV-damaged skin. J Invest Dermatol 64: 322-325, 1975.
33. Farr PM, Diffey BL: A quantitative study of the effect of topical indomethacin on cutaneous erythema induced by UVB and UVC radiation. Br J Dermatol 115: 453-466, 1986.
34. Flowers FP, Arajuo OE, Tan P: A comparative study of the effect of flurbiprofen and indomethacin on sunburn. Curr Ther Res 36: 787-791, 1984.
35. Tan P, Flowers FP, Araujo OE, et al: Effect of topically applied flurbiprofen on ultraviolet-induced erythema. Drug Intell Clin Pharm 20: 496-499, 1985.
36. Gomez EC, Trancik RJ: Effect of topical diflumidone on ultraviolet-light-induced erythema. Dermatologica 162: 175-182, 1981.
37. Lim HW, Thorbecke GJ, Baer RL, et al: Effect of indomethacin on alteration of ATPase-positive Langerhans cell density and cutaneous sunburn reaction induced by ultraviolet B radiation. J Invest Dermatol 81: 455-458, 1983.
38. Eaglstein WH, Ginsberg LD, Mertz PM: Ultraviolet irradiation-induced inflammation: effects of steroid and nonsteroid anti-inflammatory agents. Arch Dermatol 115: 1421-1423, 1979.
39. Hughes GS, Francom SF, Means LK, et al: Synergistic effects of oral non-steroidal drugs and topical corticosteroids in the therapy of sunburn in humans. Dermatology 184: 54-58, 1992.
40. Edwards EK Jr, Edwards EK: The effect of antihistamines on ultraviolet light-induced erythema. Int J Dermatol 22: 540-541, 1983.
41. Farr PM, Diffey BL, Humphreys F: A quantitative study of the effect of terfenadine on cutaneous erythema induced by UVB and UVC radiation. J Invest Dermatol 87: 771-774, 1986.
42. Werninghaus K, Meydani M, Bhawan J, et al: Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol 130: 1257-1261, 1994.
43. Eaglstein WH: Indomethacin: treatment for sunburn or investigative tool in ultraviolet inflammation? Int J Dermatol 14: 502-503, 1975.
44. Lichtenstein J, Flowers F, Sherertz EF: Nonsteroidal anti-inflammatory drugs: their use in dermatology. Int J Dermatol 26: 80-87, 1987.
45. Lee M: Prevention and treatment of nonsteroidal anti-inflammatory drug-induced gastropathy. S Med J 88: 507-513, 1995.
46. Schiodt FV, Rochling FA, Casey DL, et al: Acetaminophen toxicity in an urban county hospital. N Engl J Med 337: 1112-1117, 1997.
47. Schiodt FV, Lee WM: Acetaminophen toxicity in an urban county hospital. N Engl J Med 338: 544-545, 1998.
48. Hylek EM, Heiman H, Skates SJ, et al: Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 279: 657-662, 1998.